Research Article
Semiannual Imaging Surveillance Is Associated with Better Survival
in Patients with Non-B, Non-C Hepatocellular Carcinoma
Table 1
Clinical characteristics of the patients.
| Variable | NBNC | B/C | value | | |
| Age (yr)† | 71.0 ± 8.1 | 68.2 ± 8.9 | 0.12 | Male | 73% (22/30) | 68% (96/141) | 0.57 | Accompanied by LC | 90% (27/30) | 84% (118/141) | 0.38 | Child-Pugh (A/B, C) | 17/10 | 74/44 | 0.81 | Platelet (×104/mL)† | 13.0 ± 6.4 | 11.4 ± 5.2 | 0.16 | ALT (IU/L)‡ | 25 (8–1858) | 35 (11–320) | 0.45 | AFP (ng/mL)‡ | 6.6 (2.2–41719) | 14.1 (1.6–150300) | 0.76 | DCP (mAU/mL)‡ | 48 (9–40753) | 22 (7–99760) | 0.35 | Tumor size (mm)† | 31.4 ± 19.4 | 21.8 ± 16.0 | <0.01 | Tumor number ()† | 1.8 ± 1.5 | 1.7 ± 1.3 | 0.42 | Vascular invasion (yes/no) | 20% (6/30) | 4% (6/141) | <0.01 | TNM stage (I, II/III, and IV) | 18/12 | 108/33 | 0.06 | Curative therapy | 63% (19/30) | 68% (96/141) | 0.18 | No surveillance | 47% (14/30) | 12% (17/141) | <0.01 | Semiannual surveillance | 40% (12/30) | 57% (81/141) | 0.08 |
|
|
Mean ± SD, ‡median (range), and curative therapy which includes operative resection and radiofrequency ablation.
|